<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(11)</volume><submitter>Claria J</submitter><pubmed_abstract>&lt;h4>Background &amp; aims&lt;/h4>Patients with acutely decompensated (AD) cirrhosis are immunocompromised and particularly susceptible to infections. This study investigated the immunomodulatory actions of albumin by which this protein may lower the incidence of infections.&lt;h4>Methods&lt;/h4>Blood immunophenotyping was performed in 11 patients with AD cirrhosis and 10 healthy volunteers (HV). Bulk and single-cell RNA sequencing (scRNA-seq) and flow cytometry were performed in peripheral blood mononuclear cells (PBMCs) from 20 patients with AD cirrhosis and 34 HV exposed to albumin. Albumin's effects on degranulation, phagocytosis, chemotaxis, and swarming of neutrophils from six patients with AD cirrhosis and nine HV were assessed by measuring myeloperoxidase enzymatic activity, the engulfment of fl</pubmed_abstract><journal>JHEP reports : innovation in hepatology</journal><pagination>101184</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11490805</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis.</pubmed_title><pmcid>PMC11490805</pmcid><pubmed_authors>Marcos-Fa X</pubmed_authors><pubmed_authors>Lopez-Vicario C</pubmed_authors><pubmed_authors>Angeli P</pubmed_authors><pubmed_authors>Lozano JJ</pubmed_authors><pubmed_authors>Trebicka J</pubmed_authors><pubmed_authors>Moreau R</pubmed_authors><pubmed_authors>Marchese D</pubmed_authors><pubmed_authors>Arroyo V</pubmed_authors><pubmed_authors>Romero-Grimaldo B</pubmed_authors><pubmed_authors>Weiss E</pubmed_authors><pubmed_authors>Hernandez I</pubmed_authors><pubmed_authors>Aransay AM</pubmed_authors><pubmed_authors>Jimenez-Gracia L</pubmed_authors><pubmed_authors>Aguilar F</pubmed_authors><pubmed_authors>Vlagea A</pubmed_authors><pubmed_authors>Bernardi M</pubmed_authors><pubmed_authors>Hopke A</pubmed_authors><pubmed_authors>Cerutti A</pubmed_authors><pubmed_authors>Fernandez J</pubmed_authors><pubmed_authors>Jalan R</pubmed_authors><pubmed_authors>Muldur S</pubmed_authors><pubmed_authors>Nieto JC</pubmed_authors><pubmed_authors>Claria J</pubmed_authors><pubmed_authors>Irimia D</pubmed_authors><pubmed_authors>Casulleras M</pubmed_authors><pubmed_authors>Magri G</pubmed_authors><pubmed_authors>Giarracco E</pubmed_authors><pubmed_authors>Heyn H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis.</name><description>&lt;h4>Background &amp; aims&lt;/h4>Patients with acutely decompensated (AD) cirrhosis are immunocompromised and particularly susceptible to infections. This study investigated the immunomodulatory actions of albumin by which this protein may lower the incidence of infections.&lt;h4>Methods&lt;/h4>Blood immunophenotyping was performed in 11 patients with AD cirrhosis and 10 healthy volunteers (HV). Bulk and single-cell RNA sequencing (scRNA-seq) and flow cytometry were performed in peripheral blood mononuclear cells (PBMCs) from 20 patients with AD cirrhosis and 34 HV exposed to albumin. Albumin's effects on degranulation, phagocytosis, chemotaxis, and swarming of neutrophils from six patients with AD cirrhosis and nine HV were assessed by measuring myeloperoxidase enzymatic activity, the engulfment of fl</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-18T13:08:05.018Z</modification><creation>2025-04-06T22:40:08.353Z</creation></dates><accession>S-EPMC11490805</accession><cross_references><pubmed>39434891</pubmed><doi>10.1016/j.jhepr.2024.101184</doi></cross_references></HashMap>